VT Shareholder Representative, LLC v. Edwards Lifesciences Corp.
This text of VT Shareholder Representative, LLC v. Edwards Lifesciences Corp. (VT Shareholder Representative, LLC v. Edwards Lifesciences Corp.) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE SUPREME COURT OF THE STATE OF DELAWARE
VT Shareholder § Representative, LLC, § No. 11, 2024 § Plaintiff Below, § Appellant, § Court Below: Court of Chancery § of the State of Delaware v. § § C.A. No.: 2023-0316 § Edwards Lifesciences Corp. § and Valtech Cardio Ltd., § § Defendants Below, § Appellees. §
Submitted: July 10, 2024 Decided: July 31, 2024
Before SEITZ, Chief Justice; VALIHURA, and LEGROW, Justices.
ORDER
After consideration of the parties’ briefs and the record on appeal, it appears
to the Court that:
(1) The appellant, VT Shareholder Representative, LLC, filed this appeal
from a Court of Chancery decision granting the appellees’ motion to dismiss under
Court of Chancery Rule 12(b)(1). In its complaint, VT Shareholder claimed that
Edwards Lifesciences Corporation breached the parties’ merger agreement by
failing to use commercially reasonable efforts to achieve certain milestones that
would have triggered VT Shareholder’s right to earn-out payments. The Court of Chancery held that those claims were not ripe because the earn-out period had not
expired. VT Shareholder asserts that the Court of Chancery erred in its ripeness
determination, misinterpreted a key section of the merger agreement, and improperly
dismissed the claims based on Edwards’s misrepresentations about its ongoing
efforts to achieve the milestones.
(2) We conclude that the judgment below should be affirmed on the basis
of and for the reasons assigned by the Court of Chancery in its December 12, 2023
Memorandum Opinion granting the motion to dismiss.
(3) On May 30, 2024, while this appeal was pending, VT Shareholder
moved to supplement the record on appeal to include a quarterly report that Edwards
filed with the Securities and Exchange Commission on April 29, 2024. The report
indicates that Edwards has determined that “the probability of milestone
achievement” is “0%.”1 This Court entered an order deferring consideration of the
motion to supplement until consideration of the merits of the appeal.
(4) We conclude that the motion to supplement should be denied.
Although we do not have a court rule permitting a party to supplement the record on
appeal, our decision in Getty Oil Co. v. Heim recognizes our inherent discretion to
consider such an application.2 In Getty Oil, we explained that this Court generally
1 Appellant’s Motion to Supplement the Record May 30, 2024 (DI 26). 2 372 A.2d 529 (Del. 1977). 2 “refuses to consider evidence which was not part of the record below,” and that “[o]n
appeal, our function is to review the record, not to provide a forum to make it.”3 In
Getty Oil, however, we considered newly obtained deposition testimony of an
eyewitness to the accident because (1) exceptional circumstances existed; (2) the
deaths at issue in the case had occurred more than six years earlier; (3) the trial was
imminent; and (4) a ruling resolving the issue on appeal would have significant
implications for the trial.4
(5) The new evidence that VT Shareholder offers in this case differs
substantially from the eyewitness testimony at issue in Getty Oil. Edwards’s recent
10-Q reflects an accounting decision regarding carrying contingent liabilities on
interim financial statements. This information does not carry the same level of
urgency or the same potentially dispositive effect as the new deposition testimony
in Getty Oil.5 If anything, the ongoing developments indicate that the situation is
still evolving, and the statement in the 10-Q does not move this case into the stage
in which there is a “concrete and final,” “static” set of facts for adjudication,6 which
is the standard required for a ripe declaratory judgment action.
3 Id. at 534. 4 Id. 5 Getty Oil, 272 A.2d at 534. 6 VT Shareholder Representative, LLC v. Edwards Lifesciences Corp., 2023 WL 8597956, at *6– *7 (Del. Ch. Dec. 12, 2023). 3 (6) Moreover, it is impossible to predict how this one additional fact might
have affected the trial court’s analysis, if at all, and considering it for the first time
on appeal would contravene our long-established practice of reviewing the record
that the trial court considered, rather than considering new evidence that was not
made available to the court. Further, and again unlike Getty Oil, there is little to gain
from considering the new evidence. Nothing in the new evidence that the appellant
urges us to consider changes the fact that if Edwards ultimately fails to achieve one
or more of the milestones at the end of the earn-out period, VT Shareholder will be
able to bring an action at that time to “recover the exact same damages sought in the
present lawsuit.”7
NOW THEREFORE, IT IS ORDERED that the judgment of the Court of
Chancery is AFFIRMED and Appellant’s Motion to Supplement the record is
DENIED.
BY THE COURT:
/s/ Abigail M. LeGrow Justice
7 Id. at *9. 4
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
VT Shareholder Representative, LLC v. Edwards Lifesciences Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vt-shareholder-representative-llc-v-edwards-lifesciences-corp-del-2024.